Canada· CA-DIN-02260557
CLARITIN ALLERGY + SINUS EXTRA STRENGTH
A pseudoephedrin, kombinationen product containing loratadine + pseudoephedrine sulfate, registered in Canada by BAYER INC. The same ATC class is registered in 10 of our 19 countries.
Checked against Health Canada Drug Product Database (Canada) on
Informational only — not a medical device.
Where it is registered
Pseudoephedrin, kombinationen is registered in 10 of 19 countries.
Countries holding a registration under ATC R01BA52 (pseudoephedrin, kombinationen), each read from that country’s own register.
- This record: Canada, from Health Canada Drug Product Database (Canada)
- 6 of them publish a price we can compare per daily dose
Pseudoephedrin, kombinationen · ATC R01BA52
10 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Netherlands
- Polandprice
- United Statesprice
Price per daily dose
What a daily dose of pseudoephedrin, kombinationen costs, country by country.
Normalised to the WHO defined daily dose (0.24 g), so markets compare like for like.
- 1 market with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Pseudoephedrin, kombinationen · price per daily dose (0.24 g)
USD · FX 28 Sept 2026
- US United States$0.62 (acquisition cost)
The record
At a glance
Health Canada Drug Product Database (Canada)- Active substance
- LORATADINE + PSEUDOEPHEDRINE SULFATE
- Manufacturer
- BAYER INC
- Country
- Canada (CA)
- ATC code
- R01BA52
- ATC class
- Pseudoephedrin, Kombinationen
- Defined daily dose
- 0.24 g, O
- Reimbursed
- Not published by this register
- Source register
- Health Canada Drug Product Database (Canada)
- Last checked
- October 1, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
3 interactions on record for pseudoephedrin, kombinationen.
Mechanism, severity and management for each pair, from a commercially licensed source — included with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Pseudoephedrin, kombinationen · interactions on record
3 records
3 more interactions with mechanism and management, from a commercially licensed source.
Sign in to checkSame medicine, other countries
Pseudoephedrin, kombinationen in 6 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United Statesallergy congestion reliefKroger Company
- CzechiaCLARINASE REPETABSBAYER s.r.o., Praha
- SpainCLARITYNE PLUS 10mg/240mg COMPRIMIDOS DE LIBERACION PROLONGADABayer Hispania S.L.
- PolandClaritine ActiveBayer Sp. z o.o.
- FinlandClarinaseSchering-Plough Europe
- IcelandClarinaseBayer AB
Authorised across Europe · EMA
The same active substance is authorised in 16 EEA countries. Names it is sold under:
- Austria · Clarinase
- Belgium · Clarinase Once Daily, Clarinase Repetabs
- Bulgaria · Клариназе
- Cyprus · Clarityne-D
- Czechia · Clarinase Repetabs
- Denmark · Clarinase
- Spain · Clarityne Plus, Narine Repetabs
- Greece · Clarityne-D
- Croatia · Clarinase
- Iceland · Clarinase
- Malta · Clarinase Repetabs
- Poland · Claritine Active, Claritine Duo
- Portugal · Claridon
- Romania · Clarinase
- Slovenia · Claritine Kombo
- Slovakia · Clarinase Repetabs
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Health Canada Drug Product Database (Canada). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/0b36c2ab-e80c-49df-9acf-b8dd1b3f9abd GET /v1/drugs/0b36c2ab-e80c-49df-9acf-b8dd1b3f9abd?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"din": "02260557",
"form": "TABLET (IMMEDIATE AND EXTENDED RELEASE)",
"class": "Human",
"routes": [
"ORAL"
],
"source": "health_canada_dpd",
"status": "MARKETED",
"atc_raw": "R01BA52",
"schedule": [
"OTC"
],
"drug_code": "74601",
"strengths": [
"10 MG",
"240 MG"
],
"ahfs_class": null,
"substances": [
"LORATADINE",
"PSEUDOEPHEDRINE SULFATE"
],
"product_categorization": null
}See everything about pseudoephedrin, kombinationen.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.